本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Intellia Therapeutics Inc

9.47
-0.2300-2.37%
成交量:131.26萬
成交額:1,238.83萬
市值:10.97億
市盈率:-2.23
高:9.55
開:9.50
低:9.34
收:9.70
52周最高:28.25
52周最低:5.90
股本:1.16億
流通股本:1.02億
量比:0.61
換手率:1.29%
股息:- -
股息率:- -
每股收益(TTM):-4.2519
每股收益(LYR):-5.2506
淨資產收益率:-52.11%
總資產收益率:-28.51%
市淨率:1.47
市盈率(LYR):-1.80

資料載入中...

2020/02/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/02/27

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/27

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/09

重要事件披露

Current report, items 2.02, 8.01, and 9.01
2019/12/16

重要事件披露

Current report, item 8.01
2019/10/31

重要事件披露

Current report, items 2.02 and 9.01
2019/10/31

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/09/26

重要事件披露

Current report, item 8.01
2019/09/10

SEC問詢函

[Cover]Correspondence
2019/09/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/08/30

SEC問詢函

[Cover]Correspondence
2019/08/08

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/08/06

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/08/02

持股變動聲明

Statement of changes in beneficial ownership of securities